Kamada Ltd
NASDAQ:KMDA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kamada Ltd
NASDAQ:KMDA
|
IL |
|
P
|
Persimmon PLC
XMUN:OHP
|
UK |
|
Big Medya Teknoloji AS
IST:BIGTK.E
|
TR |
Intrinsic Value
The intrinsic value of Kamada Ltd (KMDA) under the Base Case is 10.031 USD per share.
Compared with the current market price of 7.735 USD, the stock appears
Undervalued by 23% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Kamada Does
Kamada Ltd. is a biopharmaceutical company that makes plasma-derived medicines, which are treatments made from proteins found in human blood plasma. Its products are used mainly for rare and serious conditions such as immune disorders, lung disease, and certain bleeding or deficiency problems. The company also develops some products through partnerships and sells them in regulated pharmaceutical markets.
- Headquarters
- Israel IL
- Employees
- 393
- IPO date
- Aug 1, 2005
Kamada has a narrow economic moat
Kamada Ltd has a narrow economic moat, offering limited protection against competitors and some ability to sustain profitability.
Read the full moat analysis
Earnings Waterfall
Kamada Ltd
The intrinsic value for Kamada Ltd (KMDA) under the Base Case is 10.031 USD.
Compared with the current market price of 7.735 USD, the stock appears Undervalued by 23% .